APLT vs MMC · rev $455.0K vs P/E 22, rev $24.46B
Applied Therapeutics Inc (APLT) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Applied Therapeutics Inc (APLT) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported APLT revenue for 2024-12-31 was $455.0K. Net income was -$105.6M. APLT currently screens at market cap $14.9M.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
APLT currently screens at market cap $14.9M. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the APLT and MMC stock pages for the full models.
Not investment advice.